Zura Bio slips after CEO announces medical leave

[Ceo sign on wooden elements. Ceo Concept.close up of wooden elements,Business Concept.3D rendering on blue background.]
fengdr/iStock via Getty Images

* Zura Bio (NASDAQ:ZURA [https://seekingalpha.com/symbol/ZURA]) announced that its Chief Executive Officer, Robert Lisicki, will be on medical leave starting October 10. 
* As a result, the company's stock has dropped by 3% in premarket trading.
* The company’s Board has appointed [https://investors.zurabio.com/node/9026/html]Kim Davis, Chief Operating Officer, to serve as the company’s interim CEO and interim principal executive officer, in addition to her current duties.

MORE ON ZURA BIO

* Seeking Alpha’s Quant Rating on Zura Bio [https://seekingalpha.com/symbol/ZURA/ratings/quant-ratings]
* Historical earnings data for Zura Bio [https://seekingalpha.com/symbol/ZURA/earnings]
* Financial information for Zura Bio [https://seekingalpha.com/symbol/ZURA/income-statement]